Compile Data Set for Download or QSAR
Report error Found 166 Enz. Inhib. hit(s) with all data for entry = 10306
TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526398(2-(2-(2-methoxyethyl)-2H-tetrazol-5-yl)-N-(4- (tri...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526399(2-[5-[5-fluoro-2-[4- (trifluoromethyl)anilino]phen...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526403(2-[5-[4-fluoro-2-[4- (trifluoromethyl)anilino]phen...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526406(3-((5-(2-((4- (trifluoromethyl)phenyl)amino)phenyl...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526407(2-(5-(2-fluoro-6-((4- (trifluoromethyl)phenyl)amin...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526408(2-(5-(3-fluoro-2-((4- (trifluoromethyl)phenyl)amin...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526295(US11186554, Compound 191 | 2-(5-(2-((4- (Trifluoro...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526410((2S,3S)-3-(5-(2-((4- (trifluoromethyl)phenyl)amino...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526411((2R,3R)-3-(5-(2-((4- (trifluoromethyl)phenyl)amino...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526412((2R,3S)-3-(5-(2-((4- (trifluoromethyl)phenyl)amino...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526381(3-[[5-[2-[4- (trifluoromethyl)anilino]phenyl]tetra...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526382(1-((5-(2-((4- (Trifluoromethyl)phenyl)amino)phenyl...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526394(1-((5-(2-((4- (Trifluoromethyl)phenyl)amino)phenyl...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526431(2-(2-(1-aminopropan-2-yl)-2H-tetrazol-5-yl)-N- (4-...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526290(2-(5-(2-((4- (Trifluoromethoxy)phenyl)amino)phenyl...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526295(US11186554, Compound 191 | 2-(5-(2-((4- (Trifluoro...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526441(2-(5-(5-chloro-2-((4- (trifluoromethyl)phenyl)amin...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526442(2-(5-(4-chloro-2-((4- (trifluoromethyl)phenyl)amin...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526443(2-[5-[5-methoxy-2-[4- (trifluoromethyl)anilino]phe...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526444(2-[5-[4-methoxy-2-[4- (trifluoromethyl)anilino]phe...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526413((2S,3R)-3-(5-(2-((4- (trifluoromethyl)phenyl)amino...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526418((1S,2R)-2-(5-(2-((4- (trifluoromethyl)phenyl)amino...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526420(1-((5-(2-((4- (trifluoromethyl)phenyl)amino)phenyl...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526425(2-(2-((2S,3S)-3-methoxybutan-2-yl)-2H- tetrazol-5-...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526427(2-(2-((2R,3S)-3-methoxybutan-2-yl)-2H- tetrazol-5-...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526461(2-(2-(1,3-dioxan-5-yl)-2H-tetrazol-5-yl)-N-(4- (tr...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526462(3-(5-(2-((4- (trifluoromethyl)phenyl)amino)phenyl)...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526337(ethyl 2-[5-methyl-4-[2-[4- (trifluoromethyl)anilin...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526344(3-(5-(2-((4- (trifluoromethyl)phenyl)amino)phenyl)...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526347(2-[5-[2-[4- (trifluoromethyl)anilino]phenyl]tetraz...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526348(1-[5-[2-[4- (trifluoromethyl)anilino]phenyl]tetraz...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526445(2-(5-(5-methyl-2-((4- (trifluoromethyl)phenyl)amin...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526446(2-(5-(4-methyl-2-((4- (trifluoromethyl)phenyl)amin...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526304(N-methyl-2-[5-[2-[4- (trifluoromethyl)anilino]phen...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526447(3-[[5-[2-[4- (trifluoromethyl)anilino]phenyl]tetra...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526449(2-(5-(2-((3-chloro-4- (trifluoromethyl)phenyl)amin...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526454(2-[5-[5-bromo-2-[4- (trifluoromethyl)anilino]pheny...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526455(2-(5-(5-cyclopropyl-2-((4- (trifluoromethyl)phenyl...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526456(2-[5-[5-ethyl-2-[4- (trifluoromethyl)anilino]pheny...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526458(2-(5-(5-(difluoromethoxy)-2-((4- (trifluoromethyl)...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526330(ethyl 2-(4-(2-((4- (trifluoromethyl)phenyl)amino)p...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526365(1-cyclopropyl-2-[5-[2-[4- (trifluoromethyl)anilino...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526367(2-(2-(1-methoxypropan-2-yl)-2H-tetrazol-5-yl)- N-(...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526369(1,1,1-trifluoro-3-[5-[2-[4- (trifluoromethyl)anili...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526375(1-(5-(2-((4- (trifluoromethyl)phenyl)amino)phenyl)...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526349(1-[5-[2-[4- (trifluoromethyl)anilino]phenyl]tetraz...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526350(2-[5-[2-[4- (trifluoromethyl)anilino]phenyl]tetraz...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526354(3-(5-(2-((4- (trifluoromethyl)phenyl)amino)phenyl)...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526355(ethyl 2-[5-[2-[4- (trifluoromethyl)anilino]phenyl]...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetLuciferin 4-monooxygenase(Southern Russian firefly)
Vivace Therapeutics

US Patent
LigandPNGBDBM526357(2-(2-(tetrahydrofuran-3-yl)-2H-tetrazol-5-yl)-N- (...)
Affinity DataIC50: 100nMAssay Description:HEK293T cells stably transfected with 8XTBD luciferase reporter and pRLTK in 384-well plates were treated with the test compounds, starting from 3 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

Displayed 1 to 50 (of 166 total ) | Next | Last >>
Jump to: